Keywords: sun, pharma, fiscal, 2nd-qtr, profit, soars, indian
Sun Pharma's fiscal 2nd-qtr profit soars 135%
Article | 10 November 2008
Indian generic drugmaker Sun Pharma says that its profit in the quarter ending September 30, 2008, totaled 5.13 billion rupees ($107.4 million), a 135% increase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
